Multi-trait Polygenic Probability Risk Score Enhances Glaucoma Prediction Across Ancestries

多性状多基因概率风险评分提高了跨种族人群的青光眼预测能力

阅读:1

Abstract

Primary open-angle glaucoma (POAG) remains the leading cause of irreversible blindness worldwide, with early detection crucial for preventing vision loss. However, current risk assessment methods have limited predictive power. Here, we present a multi-trait polygenic probability risk score (PPRS) approach that integrates multiple glaucoma-related traits and leverages functional genomic annotations to enhance POAG prediction across diverse ancestries. We constructed PRSs for POAG, intraocular pressure (IOP), vertical cup-to-disc ratio (VCDR), and retinal nerve fiber layer (RNFL) thickness using extensive genomic coverage (>7 million variants) and 96 functional annotations through the SBayesRC method. Validation in the UK Biobank (n=324,713, European ancestry) and Mexican American Glaucoma Genetic Study (MAGGS, n=4,549, Latino ancestry) demonstrated significant improvements in predictive accuracy over conventional approaches. Our multi-trait PPRS achieved area under the curve (AUC) values of 0.814 in Europeans and 0.801 in Latinos, compared to AUC ≤0.79 for single-trait models. We identified ancestry-specific differences in genetic contributions, with IOP demonstrating the strongest association in Europeans (OR=1.63, P = 5.37 × 10(-89)), while VCDR was predominant in Latinos (OR=1.64, P = 2.04 × 10(-11)). The model achieved remarkable risk stratification, with the highest PPRS decile showing 80.2-fold and 51.1-fold increased POAG risk in Europeans and Latinos, respectively, compared to the lowest decile. Importantly, the top PPRS quintile captured 65.9% and 62.2% of POAG cases in Europeans and Latinos, substantially improving upon previous approaches. Our findings demonstrate that integrating multiple disease-relevant traits and functional annotations significantly enhances polygenic prediction of POAG across diverse populations, with significant implications for targeted screening, early intervention, and reduction of disease burden.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。